Terms: = Brain cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Prognosis
6 results:
1. [WHO Histological Classification of Pituitary Tumors].
Nishioka H
No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
[TBL] [Abstract] [Full Text] [Related]
2. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
Xie J; Wu ZB
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
[TBL] [Abstract] [Full Text] [Related]
3. CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
[TBL] [Abstract] [Full Text] [Related]
4. CD276 and the gene signature composed of gata3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.
Takashima Y; Kawaguchi A; Hayano A; Yamanaka R
PLoS One; 2019; 14(5):e0216825. PubMed ID: 31075138
[TBL] [Abstract] [Full Text] [Related]
5. High-dose-rate brachytherapy for poor-prognosis, high-grade glioma: (phase II) preliminary results.
Micheletti E; La Face B; Feroldi P; Galelli M; Buttolo L; Stefini R; Giunta F
Tumori; 1996; 82(4):339-44. PubMed ID: 8890967
[TBL] [Abstract] [Full Text] [Related]
6. High-dose interstitial brachytherapy for glioblastoma multiforme.
Micheletti E; Baroncelli G; La Face B; Feroldi P; Galelli M; Giunta F
Tumori; 1994 Feb; 80(1):44-9. PubMed ID: 8191598
[TBL] [Abstract] [Full Text] [Related]
